Analysis Metabolite Name Measured Value Units Sample Treatment
Reversed phase NEGATIVE ION MODE1-palmitoyl-GPA (16:0)0.4030Peak areaFeces Saline
Reversed phase NEGATIVE ION MODE1-palmitoyl-GPA (16:0)0.4054Peak areaFeces Angiotensin II
Reversed phase NEGATIVE ION MODE1-palmitoyl-GPA (16:0)0.5135Peak areaFeces Angiotensin II
Reversed phase NEGATIVE ION MODE1-palmitoyl-GPA (16:0)0.5838Peak areaFeces Saline
Reversed phase NEGATIVE ION MODE1-palmitoyl-GPA (16:0)0.6562Peak areaFeces Angiotensin II
Reversed phase NEGATIVE ION MODE1-palmitoyl-GPA (16:0)0.6563Peak areaFeces Angiotensin II
Reversed phase NEGATIVE ION MODE1-palmitoyl-GPA (16:0)0.6836Peak areaFeces Saline
Reversed phase NEGATIVE ION MODE1-palmitoyl-GPA (16:0)0.7197Peak areaFeces Angiotensin II
Reversed phase NEGATIVE ION MODE1-palmitoyl-GPA (16:0)0.8204Peak areaFeces Saline
Reversed phase NEGATIVE ION MODE1-palmitoyl-GPA (16:0)0.8841Peak areaFeces Saline
Reversed phase NEGATIVE ION MODE1-palmitoyl-GPA (16:0)0.8971Peak areaFeces Saline
Reversed phase NEGATIVE ION MODE1-palmitoyl-GPA (16:0)1.1029Peak areaFeces Angiotensin II
Reversed phase NEGATIVE ION MODE1-palmitoyl-GPA (16:0)1.1917Peak areaFeces Angiotensin II
Reversed phase NEGATIVE ION MODE1-palmitoyl-GPA (16:0)1.2326Peak areaFeces Angiotensin II
Reversed phase NEGATIVE ION MODE1-palmitoyl-GPA (16:0)1.2700Peak areaFeces Saline
Reversed phase NEGATIVE ION MODE1-palmitoyl-GPA (16:0)1.4765Peak areaFeces Angiotensin II
Reversed phase NEGATIVE ION MODE1-palmitoyl-GPA (16:0)1.4935Peak areaFeces Angiotensin II
Reversed phase NEGATIVE ION MODE1-palmitoyl-GPA (16:0)2.0435Peak areaFeces Angiotensin II
Reversed phase NEGATIVE ION MODE1-palmitoyl-GPA (16:0)2.2860Peak areaFeces Saline
Reversed phase NEGATIVE ION MODE1-palmitoyl-GPA (16:0)2.8840Peak areaFeces Saline
Reversed phase NEGATIVE ION MODE1-palmitoyl-GPA (16:0)4.0431Peak areaFeces Angiotensin II
Reversed phase NEGATIVE ION MODE1-palmitoyl-GPA (16:0)5.0396Peak areaFeces Saline

Return to search page
  logo